1 Publication
2017
Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial.
Pili, Roberto⋅Pili, Roberto⋅Liu, Glenn⋅Liu, Glenn⋅Chintala, Sreenivasulu⋅Chintala, Sreenivasulu⋅Verheul, Hendrick⋅Verheul, Hendrick⋅Rehman, Shabnam⋅Rehman, Shabnam⋅Attwood, Kristopher⋅Attwood, Kristopher⋅Lodge, Martin A⋅Lodge, Martin A⋅Wahl, Richard⋅Wahl, Richard⋅Martin, James I⋅Martin, James I⋅Miles, Kiersten Marie⋅Miles, Kiersten Marie⋅Paesante, Silvia⋅Paesante, Silvia⋅Adelaiye, Remi⋅Adelaiye, Remi⋅Godoy, Alejandro⋅Godoy, Alejandro⋅King, Serina⋅King, Serina⋅Zwiebel, James⋅Zwiebel, James⋅Carducci, Michael A and Carducci, Michael A
British journal of cancer, vol. 116, (no. 7), pp. 874-883, March 28, 2017. | Journal Article